Pale Fire Capital SE, together with affiliated entities, reported a series of purchases of Phreesia, Inc. (NASDAQ: PHR) common stock that collectively amount to $10.4 million. All of the reported purchases were annotated with transaction code "P".
The transactions were carried out over three days from March 31, 2026 through April 2, 2026. On March 31, 2026, the firm acquired 1,000,500 shares at prices ranging from $7.7780 to $8.3039. On April 1, 2026, an additional 168,764 shares were bought at prices between $8.4080 and $8.5269. The activity concluded on April 2, 2026 with the purchase of 106,236 shares at $8.3061.
Following the completion of these trades, Pale Fire Capital SICAV a.s. directly holds 8,924,329 shares of Phreesia. Entities and individuals that may be deemed to beneficially own these positions include Pale Fire Capital SE, Pale Fire Capital investicni spolecnost a.s., Dusan Senkypl, and Jan Barta.
Market context for the purchases is notable. Phreesia shares have been under pressure, trading near a 52-week low of $7.77 and down 68% over the past 12 months. According to InvestingPro analysis, the stock appears undervalued at current levels, with the platform identifying 15 additional ProTips for investors assessing the healthcare technology company.
The insider buying arrives in the wake of Phreesia 27s reported fourth-quarter fiscal 2026 results, which topped consensus on several metrics. The company posted non-GAAP earnings per share of $0.33, above the consensus estimate of $0.31. Adjusted EBITDA for the quarter was $29.4 million, exceeding the expected $28.1 million.
Despite those upside results, Phreesia trimmed its fiscal 2027 revenue guidance by approximately 7%. The company attributed the reduction to lower advertising spend commitments from pharmaceutical clients, a factor it cited directly when adjusting outlook. In response to the revised guidance, Citizens reduced its coverage rating on the stock from Market Outperform to Market Perform.
Several sell-side firms updated price targets for Phreesia after the guidance change. BMO Capital lowered its target to $14.00 from $32.00 while keeping an Outperform rating. DA Davidson cut its target from $30.00 to $14.00 but maintained a Buy rating. Piper Sandler adjusted its target to $23 from $34, and KeyBanc reiterated an Overweight rating with an unchanged $28.00 price target. These adjusted outlooks reflect differing analyst interpretations of the revenue revision and its implications for valuation.
The reported purchases by Pale Fire Capital and the company 27s recent operating and guidance updates present a mixed picture: better-than-expected near-term financial performance paired with a downgraded revenue outlook that has prompted a range of analyst responses. The details reported by Pale Fire Capital indicate a concentrated purchasing program across three trading days and raise the shareholder count for the named Pale Fire entities to a direct holding of 8,924,329 shares.
Available information in this report is limited to the stated trades, ownership figures, reported financial results, the revised revenue outlook, and subsequent analyst revisions. No additional material beyond those points is asserted here.